TransMedics Group, Inc. entered into a Purchase Agreement for the sale of $400.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2028 to initial purchasers, with an option to purchase an additional $60.0 million aggregate principal amount of the Notes.